Novel crosstalk between ERK MAPK and p38 MAPK leads to homocysteine-NMDA receptor-mediated neuronal cell death

Journal of Neurochemistry

Volumn 124, Issue 4, 2013, Pages 558-570

  Poddar, Ranjana ^a   Paul, Surojit ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

crosstalk; ERK mitogen activated protein kinase; homocysteine; neuronal cell death; NMDA; p38 mitogen activated protein kinase

Indexed keywords

CALCIUM ION; HOMOCYSTEINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL STRESS; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; NERVE CELL NECROSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; RESPONSE TIME; RNA INTERFERENCE;

ANIMALS; CALCIUM; CASPASE 3; CELL DEATH; CELLS, CULTURED; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; ENZYME ACTIVATION; ENZYME INHIBITORS; EXCITATORY AMINO ACID AGENTS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GREEN FLUORESCENT PROTEINS; HOMOCYSTEINE; MAP KINASE SIGNALING SYSTEM; NEURONS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; RNA INTERFERENCE; TRANSFECTION;

EID: 84873286807     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12102     Document Type: Article

References (66)

1. Alessi D. R., Cuenda A., Cohen P., Dudley D. T., and, Saltiel A. R., (1995) PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270, 27489-27494.
2. Balazs R., (2006) Trophic effect of glutamate. Curr. Top. Med. Chem. 6, 961-968.
3. Boulton T. G., Nye S. H., Robbins D. J., Ip N. Y., Radziejewska E., Morgenbesser S. D., DePinho R. A., Panayotatos N., Cobb M. H., and, Yancopoulos G. D., (1991) ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65, 663-675.
4. Chandler L. J., Sutton G., Dorairaj N. R., and, Norwood D., (2001) N-methyl D-aspartate receptor-mediated bidirectional control of extracellular signal-regulated kinase activity in cortical neuronal cultures. J. Biol. Chem. 276, 2627-2636.
5. Chen L., Liu L., Yin J., Luo Y., and, Huang S., (2009) Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2A and 5, leading to activation of MAPK pathway. Int. J. Biochem. Cell Biol. 41, 1284-1295.
6. Choi W. S., Eom D. S., Han B. S., Kim W. K., Han B. H., Choi E. J., Oh T. H., Markelonis G. J., Cho J. W., and, Oh Y. J., (2004) Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons. J. Biol. Chem. 279, 20451-20460.
7. Cohen G. M., (1997) Caspases: the executioners of apoptosis. Biochem. J. 326 (Pt 1), 1-16.
8. Cuadrado A., and, Nebreda A. R., (2010) Mechanisms and functions of p38 MAPK signalling. Biochem. J. 429, 403-417.
9. Daniels W. M., Hendricks J., Salie R., and, Taljaard J. J., (2001) The role of the MAP-kinase superfamily in beta-amyloid toxicity. Metab. Brain Dis. 16, 175-185.
10. Davies S. P., Reddy H., Caivano M., and, Cohen P., (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95-105.
11. Duan W., Ladenheim B., Cutler R. G., Kruman I. I., Cadet J. L., and, Mattson M. P., (2002) Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease. J. Neurochem. 80, 101-110.
12. Ehlers M. D., (2000) Reinsertion or degradation of AMPA receptors determined by activity-dependent endocytic sorting. Neuron 28, 511-525.
13. Favata M. F., Horiuchi K. Y., Manos E. J., et al,. (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273, 18623-18632.
14. Ganapathy P. S., White R. E., Ha Y., Bozard B. R., McNeil P. L., Caldwell R. W., Kumar S., Black S. M., and, Smith S. B., (2011a) The role of N-methyl-D-aspartate receptor activation in homocysteine-induced death of retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 52, 5515-5524.
15. Ganapathy P. S., Perry R. L., Tawfik A., Smith R. M., Perry E., Roon P., Bozard B. R., Ha Y., and, Smith S. B., (2011b) Homocysteine-mediated modulation of mitochondrial dynamics in retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 52, 5551-5558.
16. Hardingham G. E., Fukunaga Y., and, Bading H., (2002) Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat. Neurosci. 5, 405-414.
17. Hetman M., and, Kharebava G., (2006) Survival signaling pathways activated by NMDA receptors. Curr. Top. Med. Chem. 6, 787-799.
18. Ho P. I., Ortiz D., Rogers E., and, Shea T. B., (2002) Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage. J. Neurosci. Res. 70, 694-702.
19. Houliston R. A., Pearson J. D., and, Wheeler-Jones C. P., (2001) Agonist-specific cross talk between ERKs and p38(mapk) regulates PGI(2) synthesis in endothelium. Am. J. Physiol. Cell Physiol. 281, C1266-C1276.
20. Jara-Prado A., Ortega-Vazquez A., Martinez-Ruano L., Rios C., and, Santamaria A., (2003) Homocysteine-induced brain lipid peroxidation: effects of NMDA receptor blockade, antioxidant treatment, and nitric oxide synthase inhibition. Neurotox. Res. 5, 237-243.
21. Junttila M. R., Li S. P., and, Westermarck J., (2008) Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J. 22, 954-965.
22. Keifer J., Zheng Z. Q., and, Zhu D., (2007) MAPK signaling pathways mediate AMPA receptor trafficking in an in vitro model of classical conditioning. J. Neurophysiol. 97, 2067-2074.
23. Kim M. J., Dunah A. W., Wang Y. T., and, Sheng M., (2005) Differential roles of NR2A- and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking. Neuron 46, 745-760.
24. Krapivinsky G., Medina I., Krapivinsky L., Gapon S., and, Clapham D. E., (2004) SynGAP-MUPP1-CaMKII synaptic complexes regulate p38 MAP kinase activity and NMDA receptor-dependent synaptic AMPA receptor potentiation. Neuron 43, 563-574.
25. Kruman I. I., Culmsee C., Chan S. L., Kruman Y., Guo Z., Penix L., and, Mattson M. P., (2000) Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J. Neurosci. 20, 6920-6926.
26. Kruman I. I., Kumaravel T. S., Lohani A., Pedersen W. A., Cutler R. G., Kruman Y., Haughey N., Lee J., Evans M., and, Mattson M. P., (2002) Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J. Neurosci. 22, 1752-1762.
27. Legos J. J., McLaughlin B., Skaper S. D., Strijbos P. J., Parsons A. A., Aizenman E., Herin G. A., Barone F. C., and, Erhardt J. A., (2002) The selective p38 inhibitor SB-239063 protects primary neurons from mild to moderate excitotoxic injury. Eur. J. Pharmacol. 447, 37-42.
28. Li B., Chen N., Luo T., Otsu Y., Murphy T. H., and, Raymond L. A., (2002) Differential regulation of synaptic and extra-synaptic NMDA receptors. Nat. Neurosci. 5, 833-834.
29. Lipton S. A., Kim W. K., Choi Y. B., Kumar S., D'Emilia D. M., Rayudu P. V., Arnelle D. R., and, Stamler J. S., (1997) Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc. Natl Acad. Sci. USA 94, 5923-5928.
30. Liu Y., Wong T. P., Aarts M., et al,. (2007) NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J. Neurosci. 27, 2846-2857.
31. Luo J., Kintner D. B., Shull G. E., and, Sun D., (2007) ERK1/2-p90RSK-mediated phosphorylation of Na+/H+ exchanger isoform 1. A role in ischemic neuronal death. J. Biol. Chem. 282, 28274-28284.
32. Mao L., Tang Q., Samdani S., Liu Z., and, Wang J. Q., (2004) Regulation of MAPK/ERK phosphorylation via ionotropic glutamate receptors in cultured rat striatal neurons. Eur. J. Neurosci. 19, 1207-1216.
33. Mattson M. P., and, Shea T. B., (2003) Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci. 26, 137-146.
34. Miller J. W., (1999) Homocysteine and Alzheimer's disease. Nutr. Rev. 57, 126-129.
35. Muda M., Theodosiou A., Rodrigues N., Boschert U., Camps M., Gillieron C., Davies K., Ashworth A., and, Arkinstall S., (1996) The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases. J. Biol. Chem. 271, 27205-27208.
36. Obeid R., and, Herrmann W., (2006) Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett. 580, 2994-3005.
37. Ohori M., Kinoshita T., Okubo M., et al,. (2005) Identification of a selective ERK inhibitor and structural determination of the inhibitor-ERK2 complex. Biochem. Biophys. Res. Commun. 336, 357-363.
38. Ono K., and, Han J., (2000) The p38 signal transduction pathway: activation and function. Cell. Signal. 12, 1-13.
39. Paul S., Nairn A. C., Wang P., and, Lombroso P. J., (2003) NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling. Nat. Neurosci. 6, 34-42.
40. Poddar R., and, Paul S., (2009) Homocysteine-NMDA receptor-mediated activation of extracellular signal-regulated kinase leads to neuronal cell death. J. Neurochem. 110, 1095-1106.
41. Poddar R., Sivasubramanian N., DiBello P. M., Robinson K., and, Jacobsen D. W., (2001) Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation 103, 2717-2723.
42. Poddar R., Deb I., Mukherjee S., and, Paul S., (2010) NR2B-NMDA receptor mediated modulation of the tyrosine phosphatase STEP regulates glutamate induced neuronal cell death. Journal of neurochemistry.
43. Raingeaud J., Gupta S., Rogers J. S., Dickens M., Han J., Ulevitch R. J., and, Davis R. J., (1995) Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270, 7420-7426.
44. Rakhit S., Clark C. J., O'Shaughnessy C. T., and, Morris B. J., (2005) N-methyl-D-aspartate and brain-derived neurotrophic factor induce distinct profiles of extracellular signal-regulated kinase, mitogen- and stress-activated kinase, and ribosomal s6 kinase phosphorylation in cortical neurons. Mol. Pharmacol. 67, 1158-1165.
45. Riccio A., and, Ginty D. D., (2002) What a privilege to reside at the synapse: NMDA receptor signaling to CREB. Nat. Neurosci. 5, 389-390.
46. Sacco R. L., Roberts J. K., and, Jacobs B. S., (1998) Homocysteine as a risk factor for ischemic stroke: an epidemiological story in evolution. Neuroepidemiology 17, 167-173.
47. Sato M., Suzuki K., and, Nakanishi S., (2001) NMDA receptor stimulation and brain-derived neurotrophic factor upregulate homer 1a mRNA via the mitogen-activated protein kinase cascade in cultured cerebellar granule cells. J. Neurosci. 21, 3797-3805.
48. Segal R. A., and, Greenberg M. E., (1996) Intracellular signaling pathways activated by neurotrophic factors. Annu. Rev. Neurosci. 19, 463-489.
49. Seshadri S., Beiser A., Selhub J., Jacques P. F., Rosenberg I. H., D'Agostino R. B., Wilson P. W., and, Wolf P. A., (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 346, 476-483.
50. Seth A., Gonzalez F. A., Gupta S., Raden D. L., and, Davis R. J., (1992) Signal transduction within the nucleus by mitogen-activated protein kinase. J. Biol. Chem. 267, 24796-24804.
51. Shaul Y. D., and, Seger R., (2007) The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim. Biophys. Acta 1773, 1213-1226.
52. Stanciu M., and, DeFranco D. B., (2002) Prolonged nuclear retention of activated extracellular signal-regulated protein kinase promotes cell death generated by oxidative toxicity or proteasome inhibition in a neuronal cell line. J. Biol. Chem. 277, 4010-4017.
53. Stanciu M., Wang Y., Kentor R., et al,. (2000) Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J. Biol. Chem. 275, 12200-12206.
54. Thornberry N. A., and, Lazebnik Y,. (1998) Caspases: enemies within. Science 281, 1312-1316.
55. Tuerxun T., Numakawa T., Adachi N., Kumamaru E., Kitazawa H., Kudo M., and, Kunugi H., (2010) SA4503, a sigma-1 receptor agonist, prevents cultured cortical neurons from oxidative stress-induced cell death via suppression of MAPK pathway activation and glutamate receptor expression. Neurosci. Lett. 469, 303-308.
56. Wang Z., Yang H., Tachado S. D., Capo-Aponte J. E., Bildin V. N., Koziel H., and, Reinach P. S., (2006) Phosphatase-mediated crosstalk control of ERK and p38 MAPK signaling in corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 47, 5267-5275.
57. Waxman E. A., and, Lynch D. R., (2005) N-methyl-D-aspartate receptor subtype mediated bidirectional control of p38 mitogen-activated protein kinase. J. Biol. Chem. 280, 29322-29333.
58. Xia Z., Dickens M., Raingeaud J., Davis R. J., and, Greenberg M. E,. (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326-1331.
59. Xiao Y. Q., Malcolm K., Worthen G. S., Gardai S., Schiemann W. P., Fadok V. A., Bratton D. L., and, Henson P. M., (2002) Cross-talk between ERK and p38 MAPK mediates selective suppression of pro-inflammatory cytokines by transforming growth factor-beta. J. Biol. Chem. 277, 14884-14893.
60. Yun H. Y., Gonzalez-Zulueta M., Dawson V. L., and, Dawson T. M., (1998) Nitric oxide mediates N-methyl-D-aspartate receptor-induced activation of p21ras. Proc. Natl Acad. Sci. USA 95, 5773-5778.
61. Zhang S. J., Steijaert M. N., Lau D., Schutz G., Delucinge-Vivier C., Descombes P., and, Bading H., (2007) Decoding NMDA receptor signaling: identification of genomic programs specifying neuronal survival and death. Neuron 53, 549-562.
62. Zhu X., Rottkamp C. A., Boux H., Takeda A., Perry G., and, Smith M. A., (2000) Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease. J. Neuropathol. Exp. Neurol. 59, 880-888.
63. Zhu J. J., Qin Y., Zhao M., Van Aelst L., and, Malinow R., (2002) Ras and Rap control AMPA receptor trafficking during synaptic plasticity. Cell 110, 443-455.
64. Zhu X., Raina A. K., Lee H. G., Chao M., Nunomura A., Tabaton M., Petersen R. B., Perry G., and, Smith M. A., (2003) Oxidative stress and neuronal adaptation in Alzheimer disease: the role of SAPK pathways. Antioxid. Redox Signal. 5, 571-576.
65. Zieminska E., Matyja E., Kozlowska H., Stafiej A., and, Lazarewicz J. W., (2006) Excitotoxic neuronal injury in acute homocysteine neurotoxicity: role of calcium and mitochondrial alterations. Neurochem. Int. 48, 491-497.
66. Zoccolella S., Martino D., Defazio G., Lamberti P., and, Livrea P., (2006) Hyperhomocysteinemia in movement disorders: current evidence and hypotheses. Curr. Vasc. Pharmacol. 4, 237-243.